Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,235 | 2,973 | 0 | 966 | 1,528 |
| Gross Profit | 1,235 | 2,973 | N/A | 966 | 1,528 |
| Operating Expenses | 11,773 | 12,729 | 11,914 | 11,194 | 11,107 |
| Operating Income | -10,538 | -9,756 | -11,914 | -10,228 | -9,579 |
| Interest Expense | 3,281 | 2,923 | 2,718 | 1,820 | 1,450 |
| Other Income | 16,419 | 7,198 | 23,618 | -12,973 | -8,818 |
| Pre-tax Income | 2,600 | -5,481 | 8,986 | -25,021 | -19,847 |
| Net Income Continuous | 2,600 | -5,481 | 8,986 | -25,021 | -19,847 |
| Net Income | $2,600 | $-5,481 | $8,986 | $-25,021 | $-19,847 |
| EPS Basic Total Ops | 0.07 | -0.15 | 0.25 | -0.69 | -0.55 |
| EPS Basic Continuous Ops | 0.07 | -0.15 | 0.25 | -0.69 | -0.55 |
| EPS Diluted Total Ops | 0.20 | -0.15 | -0.25 | -0.69 | -0.48 |
| EPS Diluted Continuous Ops | 0.37 | -0.15 | 0.15 | -0.69 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.15 | -0.65 | -0.69 | N/A |
| EBITDA(a) | $-10,158 | $-9,443 | $-11,599 | $-9,911 | $-9,286 |